Question 5: Magnesium sulphate for acute asthma in children

Aniapravan, R., Pullattayil, A., Al Ansari, K. and Powell, C.V.E. 2020. Question 5: Magnesium sulphate for acute asthma in children. Paediatric Respiratory Reviews 36 , pp. 112-117. 10.1016/j.prrv.2020.05.005

Full text not available from this repository.

Abstract

Most children who present to the emergency department with acute asthma, respond well to inhaled β2-agonists (spacer or nebuliser), oxygen (if required) and systemic steroids. Guidelines across the world agree on this simple, straight forward evidenced based approach. In children with more severe asthma attacks and those who do not respond to initial treatment, the evidence base for the secondary level treatment is less clear. Many regimens exist for the next step. Intravenous Magnesium Sulphate (MgSO4) is now used frequently in these situations and some centres are starting to use nebulized MgSO4 as part of the initial maximal inhaled therapy options. This paper examines the role of MgSO4 in acute asthma in children. It focusses on how MgSO4 might work, what are the current recommendations for use and then what is the current evidence base to support its use. We have presented the evidence for the use of both nebulized and intravenous MgSO4. At the end of the paper we have suggested future directions for research in this area. Our aim is to present a synthesis of the current role of MgSO4 in the management of an acute asthma attack.

Item Type:	Article
Date Type:	Publication
Status:	Published
Schools:	Medicine
Publisher:	Elsevier
ISSN:	1526-0542
Date of First Compliant Deposit:	16 November 2021
Date of Acceptance:	30 May 2020
Last Modified:	23 Nov 2021 16:45
URI:	https://orca.cardiff.ac.uk/id/eprint/145533

Citation Data

Cited 1 time in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item